
    
      This study was an open label safety and efficacy study. Each subject received a specific dose
      of a formulation containing Kaempferia parviflora. There would be attempted telephone or
      e-mail contact in 2 weeks following enrollment.

      Participants would undergo assessments of blood tests, vital signs, body weight with
      completion of questionnaires.

      The primary objective was to assess the effect of Kaempferia parviflora on erectile function
      among overall healthy males age 50 to 70.
    
  